EichorEICHOR
Condition: Recurrent C Difficile Infection Synced from ClinicalTrials.gov · August 10, 2026

Recruiting studies: Recurrent C Difficile Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Phase N/A · 4 location(s) · Bactolife A/S · NCT07250724
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Phase 3 · 215 location(s) · Vedanta Biosciences, Inc. · NCT06237452
Fecal Microbiota Transplantation for C Diff Infection
NA · 1 location(s) · Englewood Hospital and Medical Center · NCT01905709
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Phase 2/Phase 3 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06979609
Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
NA · 1 location(s) · University of Michigan · NCT07613645
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Phase 2 · 116 location(s) · AstraZeneca · NCT07285213
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Phase 3 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07328971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →